340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

HRSA Renews Contract for 340B Prime Vendor for Another Year

Exercises one-year option to continue its agreement with Apexus
 

Print Article

September 13, 2012—The Health Resources and Services Administration has opted to renew its contract with Apexus to operate the 340B Prime Vendor Program (PVP) for another year.

In 2009, HRSA signed Apexus to a two-year base contract to run PVP with three option years, the first of which HRSA exercised in October 2011.[ms-protect-content id=”2799″] Apexus is a nonprofit subsidiary of the group purchasing organization Provista. It began managing PVP under its earlier name, Healthcare Purchasing Partners International, in 2003.

PVP negotiates pharmaceutical pricing below the 340B ceiling price for participating 340B covered entities. There is no charge for providers to participate.

“We are pleased to continue our relationship with HRSA,” said Apexus Vice President Christopher Hatwig in a news release. “As the government’s prime vendor for the 340B program, we believe the program is an essential federal program, and we are committed to providing value to the eligible organizations we serve. Since our partnership began, in addition to regulatory discounts on covered outpatient drugs, the program has added numerous value-added products and services.”

The 340B program “helps improve access to affordable medications for covered entities and underserved patient groups,” Hatwig continued. Without it, “we believe many of the nation’s uninsured and under-insured would not have adequate access to affordable medications. This program helps alleviate additional financial burdens on the nation’s safety-net providers and American taxpayers.”

Apexus is one of the Office of Pharmacy Affairs’ (OPA) two main contractors. This summer, HRSA held a competition for a contractor to support its 340B program integrity efforts and perhaps take over enrolling and recertifying providers in the program. This contract agency is believed to be the successor to OPA’s Pharmacy Services Support Center (PSSC), which has been operated by the American Pharmacists Association since 2002. It is unclear when HRSA will announce the winner of the new contract competition.[/ms-protect-content]

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
8 Jun

The #340B ADR panel issued its first decision in favor of a drugmaker. We urge hospitals to contact us throughout the ADR process, because your details can help inform our advocacy. #Protect340B

Reply on Twitter 1931832357419622738 Retweet on Twitter 1931832357419622738 Like on Twitter 1931832357419622738 Twitter 1931832357419622738
340bhealth 340B Health @340bhealth ·
8 Jun

Tracking, testing, and transparency. These themes were essential for starting and maintaining @RenownHealth’s meds-to-beds program, which helps the health system deliver free drugs directly into patients’ hand before they leave the hospital. Learn more on #340BInsight:…

Reply on Twitter 1931786919714734284 Retweet on Twitter 1931786919714734284 Like on Twitter 1931786919714734284 Twitter 1931786919714734284
340bhealth 340B Health @340bhealth ·
6 Jun

Amid potential health spending cuts, rebate schemes, and other operational challenges, safety-net hospitals are still providing most of the nation’s unpaid and unreimbursed care #Becauseof340B. We must continue advocating to protect this essential lifeline for resource-strapped…

Reply on Twitter 1931089714523627657 Retweet on Twitter 1931089714523627657 Like on Twitter 1931089714523627657 1 Twitter 1931089714523627657
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health